- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: PLoS ONE 11.6 (2016)
- Schlagwort
-
-
Arzneimittelentwicklung
Arzneimitteldesign
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2016
- Urheber
-
Fuchs, Sebastian P.
Martinez-Navio, José M.
Gao, Guangping
Desrosiers, Ronald C.
- URN
-
urn:nbn:de:bvb:29-opus4-73173
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fuchs, Sebastian P.
- Martinez-Navio, José M.
- Gao, Guangping
- Desrosiers, Ronald C.
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2016
Ähnliche Objekte (12)
Adeno-Associated Virus (AAV) vectors in gene therapy
The persistence of recombinant adenoviral vectors
Recombinant IgG expression in mammalian cells
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Exploring the therapeutic potential of recombinant AAV vectors in stem cell and transplantation model systems for the treatment of heart diseases
Exploring the therapeutic potential of recombinant AAV vectors in stem cell and transplantation model systems for the treatment of heart diseases
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Receptor-targeted viral vectors: Tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Receptor-targeted viral vectors : tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Modifying the immunogenicity of AAV vectors for gene therapy and cancer immunotherapy
Generation and characterization of AAV vectors for combination immunotherapy against HIV-1
Adeno-Associated Virus (AAV) vectors in gene therapy
The persistence of recombinant adenoviral vectors
Recombinant IgG expression in mammalian cells
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Exploring the therapeutic potential of recombinant AAV vectors in stem cell and transplantation model systems for the treatment of heart diseases
Exploring the therapeutic potential of recombinant AAV vectors in stem cell and transplantation model systems for the treatment of heart diseases
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Receptor-targeted viral vectors: Tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Receptor-targeted viral vectors : tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Modifying the immunogenicity of AAV vectors for gene therapy and cancer immunotherapy
Generation and characterization of AAV vectors for combination immunotherapy against HIV-1
Adeno-Associated Virus (AAV) vectors in gene therapy
The persistence of recombinant adenoviral vectors
Recombinant IgG expression in mammalian cells
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Engineering AAV-2 targeting vectors : a new insertion site and scFv driven vectors
Exploring the therapeutic potential of recombinant AAV vectors in stem cell and transplantation model systems for the treatment of heart diseases
Exploring the therapeutic potential of recombinant AAV vectors in stem cell and transplantation model systems for the treatment of heart diseases
Adeno-associated virus display : in vitro evolution of AAV retargeted vectors
Receptor-targeted viral vectors: Tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Receptor-targeted viral vectors : tracking of stem cells and side by side comparison of AAV and lentiviral vectors
Modifying the immunogenicity of AAV vectors for gene therapy and cancer immunotherapy